Washington Manual of Medical Therapeutics
- Gallstone disease
- Gas gangrene
- Gastric cancer
- Gastric electrical stimulation
- Gastric-emptying study
- Gastric outlet obstruction
- Gastrinoma
- Gastrointestinal anthrax
- Gastrointestinal diseases
- Gastrointestinal infection
- Gastrointestinal malignancies
- Gastrointestinal stromal tumors (GIST)
- Gastroparesis
- Gemfibrozil
- Gemifloxacin
- Gender-affirming care
- Gender-affirming hormone therapy
- Gender-affirming surgery
- Gender expression
- Gender identity
- Genderqueer
- Generalized seizures
- Genetic dyslipoproteinemias [table]
- Genetic testing, hypertrophic cardiomyopathy
- Genital warts
- Genitourinary infections
- Genitourinary malignancies
- Gentamicin
- Germ cell tumors
- Gestational diabetes (GDM)
- Gestational thrombocytopenia
- Giant cell arteritis (GCA)
- Glanzmann thrombasthenia
- Glasgow Alcoholic Hepatitis Score (GAHS)
- Glioblastoma
- Glomerulopathies
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency
- α-Glucosidase inhibitors [table]
- Gluten-free diet
- Glycemic control
- Glycoprotein IIb/IIIa (GPIIb/IIIa) antagonists
- Goiter
- Gonococcal pharyngitis
- Gonorrhea [table]
- Goodpasture syndrome
- Gorlin equation
- Graded dose challenge
- Graft rejection
- Gram-negative bacillary meningitis
- Granulomas
- Granulomatous interstitial lung disease
- Graves disease
- Gravity feedings
- Group A b-hemolytic Streptococcus (GABHS) pharyngitis
- Growth hormone
- Guanabenz [table]
- Guanadrel
- Guanethidine
- Guanfacine [table]
- Gum elastic bougie
- Gynecologic malignancies